ASSEMBLY BIOSCIENCES, INC.

Analyst Reco. Assembly Biosciences, Inc.

Equities

ASMB

US0453962070

Real-time Estimate Cboe BZX Other stock markets 12:33:10 2024-05-07 pm EDT			5-day change	1st Jan Change
12.69 ^USD	-1.25%		+1.84%	+29.05%

Mar. 28	Assembly Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 19	Assembly Biosciences Insider Bought Shares Worth $511,264, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Assembly Biosciences to $1.50 From $2.50, Keeps Neutral Rating	23-03-24	MT
Mizuho Cuts Price Target on Assembly Biosciences to $3 From $14, Keeps Buy Rating	22-11-15	MT
Truist Securities Downgrades Assembly Biosciences to Hold From Buy, Adjusts Price Target to $2 From $11	22-10-24	MT
HC Wainwright Adjusts Assembly Biosciences Price Target to $2.50 From $3,50, Maintains Buy Rating	22-07-21	MT
Truist Securities Adjusts Assembly Biosciences Price Target to $12 From $15, Maintains Buy Rating	22-04-01	MT
ASSEMBLY BIOSCIENCES : HC Wainwright Starts Assembly Biosciences at Neutral with $3.50 Price Target	21-09-13	MT
ASSEMBLY BIOSCIENCES : William Blair Downgrades Assembly Biosciences to Market Perform From Outperform	21-09-02	MT
ASSEMBLY BIOSCIENCES : Mizuho Securities Adjusts Price Target on Assembly Biosciences to $14 From $13 on Lower Expenses, Reiterates Buy Rating	21-08-12	MT
ASSEMBLY BIOSCIENCES : SVB Leerink Adjusts Price Target for Assembly Biosciences to $7 From $8, Maintains Market Perform Rating	21-05-10	MT
ASSEMBLY BIOSCIENCES : SVB Leerink Downgrades Assembly Biosciences to Market Perform From Outperform, Adjusts PT to $8 From $9	21-03-23	MT
ASSEMBLY BIOSCIENCES : Jefferies Adjusts Price Target for Assembly Biosciences to $7 From $10, Maintains Hold Rating	20-12-21	MT
ASSEMBLY BIOSCIENCES : Mizuho Adjusts Assembly Biosciences' PT to $13 From $30 After H0731 'Failure in Finite Therapy;' Buy Rating Kept on Undervalued Chronic Suppressive Therapy	20-12-04	MT
ASSEMBLY BIOSCIENCES : Jefferies Downgrades Assembly Biosciences to Hold From Buy; Price Target is $10	20-11-06	MT
Assembly Biosciences, Inc. Announces Results from Research Study Evaluating the Turnover Rate of Covalently Closed Circular DNA, Which Plays Pivotal Role in the Establishment and Persistence of HBV Infection	20-04-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW